This website uses cookies

The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.

Back
  1. Home
  2. Profile of Marie Gilon (ULiège)
Profil

Gilon Marie

GIGA Cancer

Département des sciences cliniques > GIGA

Oncologie

See author's contact details
Main Referenced Co-authors
Jerusalem, Guy  (2)
Boulet, Delphine  (1)
Bours, Vincent  (1)
Fresnais, Margaux (1)
Gennigens, Christine  (1)
Main Referenced Keywords
cancer (1); oncology (1); pharmacology (1); tyrosine kinase inhibitors (1);
Main Referenced Disciplines
Oncology (2)

Publications (total 2)

The most downloaded
108 downloads
POTTIER, C., Fresnais, M., Gilon, M., JERUSALEM, G., Longuespée, R.* , & Sounni, N. E.*. (2020). Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers. doi:10.3390/cancers12030731 https://hdl.handle.net/2268/248503

The most cited

443 citations (OpenAlex)

POTTIER, C., Fresnais, M., Gilon, M., JERUSALEM, G., Longuespée, R.* , & Sounni, N. E.*. (2020). Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers. doi:10.3390/cancers12030731 https://hdl.handle.net/2268/248503

Gilon, M., Josse, C., Boulet, D., Bours, V., Waltregny, D., Jerusalem, G., & Gennigens, C. (2024). Role of eosinophils in clear-cell renal cell carcinoma. Belgian Journal of Medical Oncology.
Peer Reviewed verified by ORBi

POTTIER, C., Fresnais, M., Gilon, M., JERUSALEM, G., Longuespée, R.* , & Sounni, N. E.*. (2020). Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers. doi:10.3390/cancers12030731
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Contact ORBi